Notice: This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends DEH vs. CDRE, ESTA, AVNS, SMTI, INGN, LAKE, ZJYL, MLSS, RBOT, and APTShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Cadre (CDRE), Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Milestone Scientific (MLSS), Vicarious Surgical (RBOT), and Alpha Pro Tech (APT). D8 vs. Cadre Establishment Labs Avanos Medical Sanara MedTech Inogen Lakeland Industries Jin Medical International Milestone Scientific Vicarious Surgical Alpha Pro Tech D8 (NYSE:DEH) and Cadre (NYSE:CDRE) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings, valuation and community ranking. Which has better valuation and earnings, DEH or CDRE? Cadre has higher revenue and earnings than D8. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioD8N/AN/A-$9.46MN/AN/ACadre$482.53M3.23$38.64M$0.8346.30 Does the media favor DEH or CDRE? In the previous week, Cadre had 14 more articles in the media than D8. MarketBeat recorded 14 mentions for Cadre and 0 mentions for D8. Cadre's average media sentiment score of 0.81 beat D8's score of -0.73 indicating that Cadre is being referred to more favorably in the news media. Company Overall Sentiment D8 Negative Cadre Positive Do analysts rate DEH or CDRE? Cadre has a consensus price target of $39.75, indicating a potential upside of 3.44%. Given Cadre's stronger consensus rating and higher probable upside, analysts clearly believe Cadre is more favorable than D8.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score D8 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cadre 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do insiders and institutionals hold more shares of DEH or CDRE? 65.4% of D8 shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 37.0% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community prefer DEH or CDRE? Cadre received 16 more outperform votes than D8 when rated by MarketBeat users. CompanyUnderperformOutperformD8N/AN/ACadreOutperform Votes1655.17% Underperform Votes1344.83% Is DEH or CDRE more profitable? Cadre has a net margin of 6.34% compared to D8's net margin of 0.00%. Cadre's return on equity of 12.88% beat D8's return on equity.Company Net Margins Return on Equity Return on Assets D8N/A N/A N/A Cadre 6.34%12.88%6.06% SummaryCadre beats D8 on 12 of the 13 factors compared between the two stocks. Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$605.04M$10.15B$5.45B$20.08BDividend YieldN/A1.33%5.36%3.59%P/E RatioN/A19.7989.0141.55Price / SalesN/A26.811,253.7917.72Price / CashN/A23.5444.6520.44Price / Book116.926.025.045.79Net Income-$9.46M$182.72M$117.98M$1.01B D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$14.03-1.9%N/A+2,974.6%$605.04MN/A0.003CDRECadre2.4686 of 5 stars$31.97-0.2%$39.75+24.3%+19.7%$1.30B$516.16M38.522,240Dividend IncreaseAnalyst RevisionNews CoverageESTAEstablishment Labs2.0403 of 5 stars$33.71-26.4%$60.60+79.8%-3.6%$943.81M$153.07M-13.07960High Trading VolumeAVNSAvanos Medical4.0334 of 5 stars$15.84+4.2%N/A-17.0%$727.96M$681.50M46.593,771Positive NewsSMTISanara MedTech1.3252 of 5 stars$32.46+0.7%$47.00+44.8%+6.8%$283.73M$78.06M-32.7960Analyst ForecastAnalyst RevisionNews CoveragePositive NewsINGNInogen3.4317 of 5 stars$10.33+8.2%$7.00-32.2%+94.4%$246.04M$331.52M-4.591,030Positive NewsLAKELakeland Industries4.6299 of 5 stars$25.82-1.5%$27.50+6.5%+41.5%$191.22M$151.82M-286.891,750News CoverageGap DownZJYLJin Medical InternationalN/A$0.91+12.3%N/A-99.2%$141.05M$20.13M0.00245MLSSMilestone Scientific0.6845 of 5 stars$1.08-8.5%$1.25+15.7%+111.2%$84.12M$8.88M-15.4330Analyst ForecastNews CoverageGap DownRBOTVicarious Surgical1.563 of 5 stars$13.29+6.7%$10.25-22.9%+0.7%$78.54MN/A-1.293News CoveragePositive NewsAPTAlpha Pro TechN/A$5.63-2.4%N/A+7.1%$61.92M$59.29M15.22120Analyst ForecastNews Coverage Related Companies and Tools Related Companies CDRE Competitors ESTA Competitors AVNS Competitors SMTI Competitors INGN Competitors LAKE Competitors ZJYL Competitors MLSS Competitors RBOT Competitors APT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:DEH) was last updated on 1/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
